677 related articles for article (PubMed ID: 15563564)
1. Uremia accelerates both atherosclerosis and arterial calcification in apolipoprotein E knockout mice.
Massy ZA; Ivanovski O; Nguyen-Khoa T; Angulo J; Szumilak D; Mothu N; Phan O; Daudon M; Lacour B; Drüeke TB; Muntzel MS
J Am Soc Nephrol; 2005 Jan; 16(1):109-16. PubMed ID: 15563564
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
3. Effect of oral calcium carbonate on aortic calcification in apolipoprotein E-deficient (apoE-/-) mice with chronic renal failure.
Phan O; Ivanovski O; Nikolov IG; Joki N; Maizel J; Louvet L; Chasseraud M; Nguyen-Khoa T; Lacour B; Drüeke TB; Massy ZA
Nephrol Dial Transplant; 2008 Jan; 23(1):82-90. PubMed ID: 17977878
[TBL] [Abstract][Full Text] [Related]
4. Sevelamer prevents uremia-enhanced atherosclerosis progression in apolipoprotein E-deficient mice.
Phan O; Ivanovski O; Nguyen-Khoa T; Mothu N; Angulo J; Westenfeld R; Ketteler M; Meert N; Maizel J; Nikolov IG; Vanholder R; Lacour B; Drüeke TB; Massy ZA
Circulation; 2005 Nov; 112(18):2875-82. PubMed ID: 16267260
[TBL] [Abstract][Full Text] [Related]
5. Decreased expression of klotho gene in uremic atherosclerosis in apolipoprotein E-deficient mice.
Yu J; Deng M; Zhao J; Huang L
Biochem Biophys Res Commun; 2010 Jan; 391(1):261-6. PubMed ID: 19912987
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of aortic and cardiac dysfunction in uremic mice with aortic calcification.
Maizel J; Six I; Slama M; Tribouilloy C; Sevestre H; Poirot S; Giummelly P; Atkinson J; Choukroun G; Andrejak M; Kamel S; Mazière JC; Massy ZA
Circulation; 2009 Jan; 119(2):306-13. PubMed ID: 19118252
[TBL] [Abstract][Full Text] [Related]
7. Atherosclerosis and vascular calcification in uraemia - a new experimental model.
Ivanovski O; Nikolov IG; Drueke BT; Massy AZ
Prilozi; 2007 Dec; 28(2):11-24. PubMed ID: 18356775
[TBL] [Abstract][Full Text] [Related]
8. The antioxidant N-acetylcysteine prevents accelerated atherosclerosis in uremic apolipoprotein E knockout mice.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Ruellan N; Phan O; Lacour B; Descamps-Latscha B; Drüeke TB; Massy ZA
Kidney Int; 2005 Jun; 67(6):2288-94. PubMed ID: 15882270
[TBL] [Abstract][Full Text] [Related]
9. Chronic renal failure accelerates atherogenesis in apolipoprotein E-deficient mice.
Bro S; Bentzon JF; Falk E; Andersen CB; Olgaard K; Nielsen LB
J Am Soc Nephrol; 2003 Oct; 14(10):2466-74. PubMed ID: 14514724
[TBL] [Abstract][Full Text] [Related]
10. Arterial disease in chronic renal failure--an experimental study in the rabbit.
Tvedegaard E
Acta Pathol Microbiol Immunol Scand A; 1987; 290():1-28. PubMed ID: 3477940
[TBL] [Abstract][Full Text] [Related]
11. Repopulation of apolipoprotein E knockout mice with CCR2-deficient bone marrow progenitor cells does not inhibit ongoing atherosclerotic lesion development.
Guo J; de Waard V; Van Eck M; Hildebrand RB; van Wanrooij EJ; Kuiper J; Maeda N; Benson GM; Groot PH; Van Berkel TJ
Arterioscler Thromb Vasc Biol; 2005 May; 25(5):1014-9. PubMed ID: 15774908
[TBL] [Abstract][Full Text] [Related]
12. Effect of simvastatin in apolipoprotein E deficient mice with surgically induced chronic renal failure.
Ivanovski O; Szumilak D; Nguyen-Khoa T; Nikolov IG; Joki N; Mothu N; Maizel J; Westenfeld R; Ketteler M; Lacour B; Drüeke TB; Massy ZA
J Urol; 2008 Apr; 179(4):1631-6. PubMed ID: 18295249
[TBL] [Abstract][Full Text] [Related]
13. Uremia-specific effects in the arterial media during development of uremic atherosclerosis in apolipoprotein E-deficient mice.
Bro S; Borup R; Andersen CB; Moeller F; Olgaard K; Nielsen LB
Arterioscler Thromb Vasc Biol; 2006 Mar; 26(3):570-5. PubMed ID: 16373611
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of aortic remodeling in apolipoprotein E-deficient mice and renovascular hypertensive mice.
Nogueira BV; Peotta VA; Meyrelles SS; Vasquez EC
Arch Med Res; 2007 Nov; 38(8):816-21. PubMed ID: 17923260
[TBL] [Abstract][Full Text] [Related]
15. Prolonged high-fat feeding enhances aortic 18F-FDG and 99mTc-annexin A5 uptake in apolipoprotein E-deficient and wild-type C57BL/6J mice.
Zhao Y; Kuge Y; Zhao S; Strauss HW; Blankenberg FG; Tamaki N
J Nucl Med; 2008 Oct; 49(10):1707-14. PubMed ID: 18794270
[TBL] [Abstract][Full Text] [Related]
16. Macrophage phospholipid transfer protein deficiency and ApoE secretion: impact on mouse plasma cholesterol levels and atherosclerosis.
Liu R; Hojjati MR; Devlin CM; Hansen IH; Jiang XC
Arterioscler Thromb Vasc Biol; 2007 Jan; 27(1):190-6. PubMed ID: 17038631
[TBL] [Abstract][Full Text] [Related]
17. Ticlopidine attenuates progression of atherosclerosis in apolipoprotein E and low density lipoprotein receptor double knockout mice.
Jawien J; Csanyi G; Gajda M; Mateuszuk L; Lomnicka M; Korbut R; Chlopicki S
Eur J Pharmacol; 2007 Feb; 556(1-3):129-35. PubMed ID: 17174298
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-related apoptosis-inducing ligand and vascular calcification.
Chasseraud M; Liabeuf S; Mozar A; Mentaverri R; Brazier M; Massy ZA; Kamel S
Ther Apher Dial; 2011 Apr; 15(2):140-6. PubMed ID: 21426505
[TBL] [Abstract][Full Text] [Related]
19. Lack of the cysteine protease inhibitor cystatin C promotes atherosclerosis in apolipoprotein E-deficient mice.
Bengtsson E; To F; Håkansson K; Grubb A; Brånén L; Nilsson J; Jovinge S
Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2151-6. PubMed ID: 16051881
[TBL] [Abstract][Full Text] [Related]
20. Reduced atherosclerotic lesions in P2Y1/apolipoprotein E double-knockout mice: the contribution of non-hematopoietic-derived P2Y1 receptors.
Hechler B; Freund M; Ravanat C; Magnenat S; Cazenave JP; Gachet C
Circulation; 2008 Aug; 118(7):754-63. PubMed ID: 18663083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
